Multi-country medical and recreational cannabis operator, IM Cannabis (CSE: IMCC) (NASDAQ: IMCC) confirmed Friday it has completed its previously announced acquisition of MYM Nutraceuticals MYM valued at CA$85 million ($67.6 million).
MYM is a Canadian cultivator, processor and distributor of cannabis through its two wholly-owned subsidiaries - SublimeCulture Inc. and Highland Grow Inc.
The transaction was finalized under the terms and conditions of an agreement between IMC, MYM and Trichome Financial Corp that resulted in the acquisition by IMC of all the issued and outstanding shares of MYM. Following the finalization of the acquisition, IMC indirectly (via its wholly-owned subsidiary Trichome Financial Corp.) has ownership and control over 100% of the issued and outstanding MYM shares.
Under the deal, ex MYM shareholders obtained a total of 10.07 million IMC shares or around 15% of the total number of the issued and outstanding IMC shares. The MYM shares will be delisted from the Canadian Securities Exchange around July 9.
"We are extremely pleased to have closed the acquisition of MYM. Strategically, this Transaction is consistent with IMC's focus on premium and super-premium segments of the cannabis market for consumers and patients in all markets,” Oren Shuster, CEO of IMC stated. “With coast-to-coast distribution, including a strong leadership position in Eastern Canada, Highland Grow will further enhance our distribution capabilities, fast-track our entrance into new markets, and results in additional opportunities to export premium cannabis products to Israel and Germany.”
In connection to the transaction, Desjardins Capital Markets and Torys LLP acted as financial advisor and legal counsel, respectively, to IMC. Hyperion Capital Inc. and Borden Ladner Gervais LLP acted as financial advisor and legal counsel, respectively, to MYM.
Price Action
IMC shares were trading 2.38% lower at $4.92 per share at the time of writing Friday morning.
Photo: Courtesy of IM Cannabis
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.